Page 21 - Read Online
P. 21

Page 14 of 20                                                                                      Nappi et al. Vessel Plus 2021;5:40  https://dx.doi.org/10.20517/2574-1209.2021.06


                              Table 3. Baseline characteristics of all patients in surgical approach groups [36-44]

                                                                                                                 r-MVR      r-MVr      Age, y,        STS       NYHA Class III or  LVEF (%; mean ±  Heart
                                                                              Overall Sternotomy Thoracotomy
                                                                                                                 (%)        (%)        median         score     IV                 SD)                failure

                              4 institutions within the Northwell Healt System  256   166          90            145 (56.6)  111 (43.4)  62.2 ± 14.7  8.1 ± 0.09 93 (56)           52.9 ± 12.6
                              Single Surgical Team (autors ACA and DHA)       53      44           9             45 (84.9)  8 (15.1)   57 ± 13.2                34 (64)            54.3 ± 10.8
                              Division of Cardiac Surgery of Maryland School of   130  130         0             41 (31)    39 (30)    62 ± 15                  96 (74)            51 ± 12
                              Medicine
                              Mayo Clinic Rochester                           145     N.I.         N.I.          81 (56%)   64 (44)                             69 (47,5)          (n = 136)

                              Re-repair                                       64                                                       64 ± 13                                     57 ± 12
                              Replacement                                     81                                                       67 ± 11                                     56 ± 11

                              Michigan Medical Centre                         450     0            450                                                          NYHA Class
                              Fibrillatory Arrest                             134     0            134           55 (41.1)  79 (58.9)  63 ± 13                  2.7 ± 0.8          36 ± 13

                              Beating heart                                   316     0            316           101 (33)   215 (67)   63 ± 15                  2.6 ± 0.7          38 ± 9
                              Pennsylvania Health System                      305     249          56            257        48                                                     LVEF < 40% (%)

                              Re-repair                                                                                                61 ± 16                  N.I.               10 (19)
                              Replacement                                                                                              62 ± 15                  N.I.               38 (15)
                              Medicare Provider Analysis and Review           1627                               815        812        74                                                             1275

                              Re-repair                                       285
                              Replacement                                     1332

                              A 10-year single-centre experience              49                                 49                    63 ± 13
                              Division of Cardiovascular Surgery, Toronto General   513                                                57 ± 13                  227 (44)           < 40% (15%)
                              Hospital


                              STS: Society of Thoracic Surgeons; NYHA: New York Heart Association; LVEF: left ventricle ejection fraction; r-MVR: redo mitral valve replacement; r-MVr: redo mitral valve repair; N.I.: not indicated.



                              Regarding TMViV-T, the following is fundamental. First, the evaluation of clinically relevant endpoints should reflect the safety and efficacy of MRI
                              treatments. Second, consistent clinical definitions for these endpoints should be used across the relevant studies. The use of TMViV-T as mechanical

                              intervention is aimed to change the extent of the survival benefit. In contrast, the evidence on the use of a standard surgical approach has consistently shown
                              favorable results, and this option has gained the support of the surgical community.
   16   17   18   19   20   21   22   23   24   25   26